Quince Therapeutics, Inc. (QNCX)
NASDAQ: QNCX · Real-Time Price · USD
28.85
+0.25 (0.89%)
At close: Sep 15, 2026, 4:00 PM EDT
29.90
+1.05 (3.66%)
After-hours: Sep 15, 2026, 7:30 PM EDT
Quince Therapeutics Market Cap
Quince Therapeutics has a market cap or net worth of $29.34 million as of September 15, 2026. Its market cap has decreased by -65.86% in one year.
Market Cap
29.34M
Enterprise Value
-86.64M
1-Year Change
-65.86%
Ranking
Category
Stock Price
$28.85
ChartMarket Cap Chart
Since May 9, 2019, Quince Therapeutics's market cap has decreased from $855.57M to $29.34M, a decrease of -96.57%. That is a compound annual growth rate of -36.77%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 15, 2026 | 29.34M | -84.27% |
| Dec 31, 2025 | 186.53M | 126.70% |
| Dec 31, 2024 | 82.28M | 82.80% |
| Dec 29, 2023 | 45.01M | 95.46% |
| Dec 30, 2022 | 23.03M | -93.89% |
| Dec 31, 2021 | 377.06M | -53.99% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 9, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Context Therapeutics | 32.25M |
| Aligos Therapeutics | 31.47M |
| BeyondSpring | 31.25M |
| BriaCell Therapeutics | 31.13M |
| NextCure | 30.39M |
| IGC Pharma | 28.48M |
| Quantum BioPharma | 27.98M |
| TransCode Therapeutics | 27.94M |